Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rho Kinase in Atherosclerosis: Atorvastatin vs Rosuvastatin
NCT00115830Phase 3Completed
- Sponsor
- Brigham and Women's Hospital
- Start
- Dec 2004
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in atherosclerosis comparing Atorvastatin Arm with Rosuvastatin Arm (2 arms). Started Dec 2004; status: completed.
02
Drugs
atorvastatinrosuvastatin
03
Conditions
atherosclerosis
Beyond the preview
Go deeper on NCT00115830.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00115830.